The Potentially Therapeutic Role of EPAC in Curbing the Process of Idiopathic Pulmonary Fibrosis via Differential Cellular Pathways
Open Access
- 1 February 2021
- journal article
- research article
- Published by Taylor & Francis Ltd in Journal of Inflammation Research
- Vol. ume 14, 611-619
- https://doi.org/10.2147/jir.s296382
Abstract
Idiopathic pulmonary fibrosis (IPF) is a chronic progressive fibrosis disease caused by genetic susceptibility (causative) and other indirect risk factors such as smoking, micro-aspiration and air pollution. Repeated damage of lung epithelial cells can cause fibroblast activation and excessive collagen will lead the scar formation and severe fibrosis. It has been decades since drugs for the treatment of IPF were developed, but clinical choices were limited. Exchange Protein directly Activated by cAMP (EPAC), as a newly emerging cAMP (adenosine 3ʹ,5ʹ-cyclic monophosphate) downstream molecule, plays a vital role in the cellular pathways of IPF such as inhibiting fibroblast proliferation, stress fiber formation and epithelium cell adhesion, so it may be a novel target for drug development and treatment for curbing IPF. Here, we hypothesize that EPAC may participate in the signaling pathways related to IPF in different cell types (fibroblasts; airway smooth muscle cells; vascular endothelial cells; lung epithelial cells; macrophages; mesenchymal stem cells; T cells), thereby playing a potentially therapeutic role in resisting the process of fibrosis. We summarize the current correlation between EPAC and IPF in these different cell types, and further insights into EPAC will help to optimize the pharmacological treatment for IPF.Keywords
This publication has 57 references indexed in Scilit:
- DNA Methylation of Alternative Promoters Directs Tissue Specific Expression of Epac2 IsoformsPLOS ONE, 2013
- Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literatureEuropean Respiratory Review, 2012
- cAMP and Epac in the regulation of tissue fibrosisBritish Journal of Pharmacology, 2012
- Protective and pathogenic functions of macrophage subsetsNature Reviews Immunology, 2011
- The cAMP-responsive Rap1 Guanine Nucleotide Exchange Factor, Epac, Induces Smooth Muscle Relaxation by Down-regulation of RhoA ActivityPublished by Elsevier BV ,2011
- Endothelial–Mesenchymal Transition in Bleomycin-Induced Pulmonary FibrosisAmerican Journal of Respiratory Cell and Molecular Biology, 2010
- Direct Spatial Control of Epac1 by Cyclic AMPMolecular and Cellular Biology, 2009
- Prostaglandin E2 Inhibits Specific Lung Fibroblast Functions via Selective Actions of PKA and Epac-1American Journal of Respiratory Cell and Molecular Biology, 2008
- The cyclic AMP effector Epac integrates pro- and anti-fibrotic signalsProceedings of the National Academy of Sciences of the United States of America, 2008
- Exchange Protein Activated by Cyclic AMP (Epac)-Mediated Induction of Suppressor of Cytokine Signaling 3 (SOCS-3) in Vascular Endothelial CellsMolecular and Cellular Biology, 2006